vs

Side-by-side financial comparison of USA Compression Partners, LP (USAC) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

USA Compression Partners, LP is the larger business by last-quarter revenue ($252.5M vs $127.1M, roughly 2.0× Zai Lab Ltd). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs 2.7%). USA Compression Partners, LP produced more free cash flow last quarter ($87.7M vs $-26.7M). Over the past eight quarters, Zai Lab Ltd's revenue compounded faster (20.8% CAGR vs 4.9%).

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

USAC vs ZLAB — Head-to-Head

Bigger by revenue
USAC
USAC
2.0× larger
USAC
$252.5M
$127.1M
ZLAB
Growing faster (revenue YoY)
ZLAB
ZLAB
+14.4% gap
ZLAB
17.1%
2.7%
USAC
More free cash flow
USAC
USAC
$114.4M more FCF
USAC
$87.7M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
ZLAB
ZLAB
Annualised
ZLAB
20.8%
4.9%
USAC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
USAC
USAC
ZLAB
ZLAB
Revenue
$252.5M
$127.1M
Net Profit
$27.8M
Gross Margin
51.0%
Operating Margin
30.3%
-54.6%
Net Margin
11.0%
Revenue YoY
2.7%
17.1%
Net Profit YoY
9.1%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
USAC
USAC
ZLAB
ZLAB
Q4 25
$252.5M
$127.1M
Q3 25
$250.3M
$115.4M
Q2 25
$250.1M
$109.1M
Q1 25
$245.2M
$105.7M
Q4 24
$245.9M
$108.5M
Q3 24
$240.0M
$101.8M
Q2 24
$235.3M
$100.1M
Q1 24
$229.3M
$87.1M
Net Profit
USAC
USAC
ZLAB
ZLAB
Q4 25
$27.8M
Q3 25
$34.5M
$-36.0M
Q2 25
$28.6M
$-40.7M
Q1 25
$20.5M
$-48.4M
Q4 24
$25.4M
Q3 24
$19.3M
$-41.7M
Q2 24
$31.2M
$-80.3M
Q1 24
$23.6M
$-53.5M
Gross Margin
USAC
USAC
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
64.9%
Q1 24
61.4%
Operating Margin
USAC
USAC
ZLAB
ZLAB
Q4 25
30.3%
-54.6%
Q3 25
33.5%
-42.3%
Q2 25
30.6%
-50.3%
Q1 25
28.3%
-53.3%
Q4 24
30.3%
-62.6%
Q3 24
31.5%
-66.6%
Q2 24
32.9%
-76.0%
Q1 24
29.2%
-80.7%
Net Margin
USAC
USAC
ZLAB
ZLAB
Q4 25
11.0%
Q3 25
13.8%
-31.2%
Q2 25
11.4%
-37.3%
Q1 25
8.4%
-45.8%
Q4 24
10.3%
Q3 24
8.1%
-40.9%
Q2 24
13.3%
-80.2%
Q1 24
10.3%
-61.4%
EPS (diluted)
USAC
USAC
ZLAB
ZLAB
Q4 25
$-0.05
Q3 25
$-0.03
Q2 25
$-0.04
Q1 25
$-0.04
Q4 24
$-0.09
Q3 24
$-0.04
Q2 24
$-0.08
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
USAC
USAC
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$8.6M
$689.6M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$715.5M
Total Assets
$2.6B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
USAC
USAC
ZLAB
ZLAB
Q4 25
$8.6M
$689.6M
Q3 25
$717.2M
Q2 25
$2.0K
$732.2M
Q1 25
$2.0K
$757.3M
Q4 24
$14.0K
$779.7M
Q3 24
$79.0K
$616.1M
Q2 24
$9.0K
$630.0M
Q1 24
$8.0K
$650.8M
Total Debt
USAC
USAC
ZLAB
ZLAB
Q4 25
$2.5B
Q3 25
$2.5B
Q2 25
$2.5B
Q1 25
$2.5B
Q4 24
$2.5B
Q3 24
$2.5B
Q2 24
$2.5B
Q1 24
$2.5B
Stockholders' Equity
USAC
USAC
ZLAB
ZLAB
Q4 25
$715.5M
Q3 25
$759.9M
Q2 25
$791.7M
Q1 25
$810.8M
Q4 24
$840.9M
Q3 24
$667.7M
Q2 24
$704.2M
Q1 24
$762.2M
Total Assets
USAC
USAC
ZLAB
ZLAB
Q4 25
$2.6B
$1.2B
Q3 25
$2.7B
$1.2B
Q2 25
$2.7B
$1.2B
Q1 25
$2.7B
$1.2B
Q4 24
$2.7B
$1.2B
Q3 24
$2.8B
$985.3M
Q2 24
$2.8B
$987.4M
Q1 24
$2.8B
$988.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
USAC
USAC
ZLAB
ZLAB
Operating Cash FlowLast quarter
$139.5M
$-26.0M
Free Cash FlowOCF − Capex
$87.7M
$-26.7M
FCF MarginFCF / Revenue
34.8%
-21.0%
Capex IntensityCapex / Revenue
20.5%
0.5%
Cash ConversionOCF / Net Profit
5.02×
TTM Free Cash FlowTrailing 4 quarters
$277.0M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
USAC
USAC
ZLAB
ZLAB
Q4 25
$139.5M
$-26.0M
Q3 25
$75.9M
$-32.0M
Q2 25
$124.2M
$-31.0M
Q1 25
$54.7M
$-61.7M
Q4 24
$130.2M
$-55.8M
Q3 24
$48.5M
$-26.8M
Q2 24
$96.7M
$-42.2M
Q1 24
$65.9M
$-90.1M
Free Cash Flow
USAC
USAC
ZLAB
ZLAB
Q4 25
$87.7M
$-26.7M
Q3 25
$51.9M
$-35.0M
Q2 25
$101.1M
$-33.9M
Q1 25
$36.3M
$-63.2M
Q4 24
$101.2M
$-58.4M
Q3 24
$19.8M
$-28.2M
Q2 24
$48.2M
$-42.9M
Q1 24
$-32.7M
$-91.1M
FCF Margin
USAC
USAC
ZLAB
ZLAB
Q4 25
34.8%
-21.0%
Q3 25
20.7%
-30.4%
Q2 25
40.4%
-31.1%
Q1 25
14.8%
-59.9%
Q4 24
41.1%
-53.8%
Q3 24
8.2%
-27.7%
Q2 24
20.5%
-42.9%
Q1 24
-14.3%
-104.5%
Capex Intensity
USAC
USAC
ZLAB
ZLAB
Q4 25
20.5%
0.5%
Q3 25
9.6%
2.6%
Q2 25
9.3%
2.6%
Q1 25
7.5%
1.5%
Q4 24
11.8%
2.4%
Q3 24
12.0%
1.3%
Q2 24
20.6%
0.7%
Q1 24
43.0%
1.1%
Cash Conversion
USAC
USAC
ZLAB
ZLAB
Q4 25
5.02×
Q3 25
2.20×
Q2 25
4.35×
Q1 25
2.66×
Q4 24
5.12×
Q3 24
2.51×
Q2 24
3.10×
Q1 24
2.80×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons